Cambridge, United Kingdom

Andrey Arzumanov

This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: United Kingdom Research and Innovation, Oxford University Innovation Ltd. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrey Arzumanov. Retrieved from https://idiyas.com/inventor/andrey-arzumanov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.9

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Andrey Arzumanov

Introduction

Andrey Arzumanov is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly through his work on cell-penetrating peptides. His innovative approach has the potential to impact the treatment of genetic disorders, including muscular dystrophies.

Latest Patents

Arzumanov holds a patent related to cell-penetrating peptides. This invention focuses on peptides that can penetrate cell membranes and their conjugates with therapeutic molecules. The patent outlines the use of these peptides or conjugates in treatment methods, especially for genetic disorders such as Duchenne muscular dystrophy. He has 1 patent to his name.

Career Highlights

Throughout his career, Arzumanov has worked with prominent organizations, including Oxford University Innovation Limited and United Kingdom Research and Innovation. His work in these institutions has allowed him to advance his research and collaborate with other experts in the field.

Collaborations

Some of his notable coworkers include Matthew Wood and Raquel Manzano. Their collaboration has contributed to the development of innovative solutions in biotechnology.

Conclusion

Andrey Arzumanov's work in cell-penetrating peptides showcases his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in the treatment of genetic disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…